Armando Stano

Armando Stano is currently a Senior Advisor in Antibody Discovery at Eli Lilly and Company, where they leverage their extensive background in health sciences and aspiring communication skills within the biotechnology sector. They previously held positions as a Scientist in Antibody Discovery at AlivaMab Discovery Services LLC and as a Principal Scientist at Antharis Therapeutics, where they established high throughput laboratories and developed therapeutic monoclonal antibodies. Their academic qualifications include a PhD in Biotechnology and Bioengineering from École Polytechnique Fédérale de Lausanne, and a Master's and Bachelor's in Medical Biotechnology from the University of Rome "La Sapienza." Throughout their career, Armando has conducted significant research in virology, vaccine immunology, and antibody discovery, with a focus on enhancing immune responses for protective immunity.